Sunshine Biopharma Inc. (SBFM): Capital Expenditures
$174.5K
Year ended 2025-12-31
$19.1K
Trailing 12 months to 2026-06-30
-3.5%
3-year compound annual growth
n/m
5-year compound annual growth
+43.3%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $174.5K | -89.5% | 2026-04-03, From 2025-01-01 |
| 2024-12-31 | $1.66M | n/m | 2026-04-03, From 2024-01-01 |
| 2023-12-31 | $82.3K | -57.6% | 2025-04-01, From 2023-01-01 |
| 2022-12-31 | $194.0K | n/a | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $0 | -100.0% | 2023-04-04, From 2021-01-01 |
| 2020-12-31 | $1.2K | +38.5% | 2022-03-21, From 2020-01-01 |
| 2019-12-31 | $860 | -95.4% | 2021-03-30, From 2019-01-01 |
| 2018-12-31 | $18.9K | +407.0% | 2020-05-01, From 2018-01-01 |
| 2017-12-31 | $3.7K | +8.1% | 2019-04-12, From 2017-01-01 |
| 2016-12-31 | $3.4K | -28.2% | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | $4.8K | n/a | 2017-04-17, From 2015-01-01 |
| 2014-12-31 | $0 | n/a | 2016-03-25, From 2014-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $174.5K | -89.5% |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $121.6K | -61.2% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $756.6K | +0.5% |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | $0 | -100.0% |
| BGM Group Ltd. (BGM) | 2025-09-30 | $1.57M | +552.4% |
| Bioharvest Sciences Inc. (BHST) | 2025-12-31 | $2.35M | -16.9% |
| Zomedica Corp. (ZOMDF) | 2025-12-31 | $567.0K | -89.1% |
| Biofrontera Inc. (BFRI) | 2025-12-31 | $2.0K | -80.0% |
| Verastem, Inc. (VSTM) | 2024-12-31 | $28.0K | n/a |
Compare SBFM, LIFD, ETST, VRCA side by side · Screen every company in Pharmaceutical Preparations ↗